DefiniGENS’s human IPSC platform generates high quality wild-type and diseased cell models.
DefiniGEN's human iPSC platform generates high quality wild-type and diseased cell models. In addition our platform allows us to generates custom disease modelled hepatocytes
We can produce human iPSC-derived intestinal organoids that provide a unique in vitro system to model the human intestine. In addition we have a monolayer format to study intestinal permeability
Our technology platform produces human iPSC-derived pancreatic beta cells with a dose dependent glucose sensitive insulin secretion (GSIS) response. We also provide monogenic and complex diabetes disease model variants
